Home LiteratureArticle Details
PMID: 2187505 Published · ppublish English Journal Article

High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing.

AIDS research and human retroviruses ·Vol. 6 ·No. 4 ·1990-04-00 ·Pages 561-5

Kwok S, Gallo D, Hanson C, McKinney N, Poiesz B, Sninsky JJ

Abstract

The polymerase chain reaction (PCR) was used to confirm the presence of human T-cell lymphotropic viruses (HTLV) in intravenous drug users (IVDU) whose sera were reactive by immunofluorescence assay (IFA) for HTLV-1/-II antibody. Peripheral blood mononuclear cells from 41 IFA-positive and 19 IFA-negative individuals were analyzed. HTLV sequences were detected in 39/41 IFA-positive samples; 36 were HTLV-II positive and 3 were HTLV-I positive. Two IFA antibody-positives were negative by both PCR and by enzyme immunoassay (EIA). One IFA and EIA antibody-negative sample was positive for HTLV-II by PCR. This study indicates a high prevalence of HTLV-II among IVDUs and further demonstrates the feasibility of using PCR to differentiate between HTLV-I and -II.

MeSH Terms
Fluorescent Antibody Technique Human T-lymphotropic virus 1/genetics,isolation & purification Human T-lymphotropic virus 2/genetics,isolation & purification Humans Immunoenzyme Techniques Polymerase Chain Reaction Substance Abuse, Intravenous/microbiology
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kwok S
Department of Infectious Diseases, Cetus Corporation, Emeryville, CA.
Gallo D
Hanson C
McKinney N
Poiesz B
Sninsky J J
Article Info
Journal
AIDS research and human retroviruses
Abbr.
AIDS Res Hum Retroviruses
ISSN
0889-2229
Published
1990-04-00
Pages
561-5
Language
English
Region
United States
NLM ID
8709376
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com